Mangoceuticals, Inc. - Common Stock

MGRX31

Penny Stock

$0.26arrow_drop_down1.74%-$0.00

Penny Stock

MGRX31

$0.26

arrow_drop_down1.74%-$0.00

Penny Stock

Performance History

Key Stats
Open	$0.26
Prev. Close	$0.26
EPS	-0.43
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$8.07M
PE Ratio	-

	LOW	HIGH
Day Range	0.26	0.27
52 Week Range	0.14	1.19

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.43

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Mangoceuticals, Inc. - Common Stock (MGRX)

Mangoceuticals, Inc. - Common Stock (MGRX) is a publicly traded company in the health and wellness industry. The company specializes in the development and distribution of products derived from mangoes, known for their numerous health benefits. With a focus on natural and organic ingredients, Mangoceuticals aims to provide consumers with high-quality and innovative wellness solutions. The stock price history of MGRX reflects the market's interest in the company's potential.

As of the latest quote, Mangoceuticals, Inc. - Common Stock (MGRX) is trading at a value that indicates investor confidence. The stock news surrounding MGRX is positive, with the company consistently releasing updates on its latest product launches, partnerships, and performance. This has contributed to the company's market cap, which is a measure of its total market value, steadily growing.

Websitecall_made

Sector: Healthcare
Industry: Health Information Services
CEO: Mr. Jacob D. Cohen
Headquarters: Dallas
Employees: 2
Exchange: NASDAQ

add Mangoceuticals, Inc. - Common Stock to watchlist

Keep an eye on Mangoceuticals, Inc. - Common Stock

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Mangoceuticals, Inc. - Common Stock's (MGRX) price per share?

The current price per share for Mangoceuticals, Inc. - Common Stock (MGRX) is $0.27. The stock has seen a price change of -$0 recently, indicating a -1.74% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Mangoceuticals, Inc. - Common Stock (MGRX)?

For Mangoceuticals, Inc. - Common Stock (MGRX), the 52-week high is $1.12, which is 322.16% from the current price. The 52-week low is $0.14, the current price is 85.52% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Mangoceuticals, Inc. - Common Stock (MGRX) a growth stock?

Mangoceuticals, Inc. - Common Stock (MGRX) has shown an average price growth of 0.41% over the past three years. It has received a score of -6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Mangoceuticals, Inc. - Common Stock as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Mangoceuticals, Inc. - Common Stock (MGRX) stock price performance year to date (YTD)?

As of the latest data, Mangoceuticals, Inc. - Common Stock (MGRX) has a year-to-date price change of -8.64%. Over the past month, the stock has experienced a price change of -17.09%. Over the last three months, the change has been -11.54%. Over the past six months, the figure is 49.8%.

help

Is Mangoceuticals, Inc. - Common Stock (MGRX) a profitable company?

Mangoceuticals, Inc. - Common Stock (MGRX) has a net income of -$9.21M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 58.99% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.3K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $431.5K. Operating income is noted at -$9.22M. Furthermore, the EBITDA is -$8.51M.

help

What is the market capitalization of Mangoceuticals, Inc. - Common Stock (MGRX)?

Mangoceuticals, Inc. - Common Stock (MGRX) has a market capitalization of $8.07M. The average daily trading volume is 245.43K, indicating the stock's liquidity and investor engagement.